Identification of mycoplasma contamination in cell culture

Tetiana Тkachenko, M. Kokovin, P. Drozd, Svitlana Prylutska
Abstract

Mycoplasmas are the smallest and simplest prokaryotes that localise to the endosomes of mammalian cells and are quite common contaminants of cell cultures. In this study, we identified mycoplasma infection in a cell culture of the human breast cancer cell line BR using phase-contrast and fluorescence microscopy with 4,6-diamidino-2-phenylindole (DAPI) staining, which has affinity for nucleolar DNA. Breast cancer cells infected with mycoplasma have increased granularity (phase contrast microscopy), and when fluorescence microscopy is used, mycoplasma DNA appears as fluorescent spots concentrated in the cytoplasm of infected cells and outside them. It has been shown that mycoplasma contamination does not affect the number of tumour cells in culture, but may probably affect the course of their physiological and biochemical functions. To treat mycoplasma infection in cell culture, two antibiotics were used: tiamulin (macrolide group) and minocycline (tetracycline group) at a concentration of 5 mM each. The effectiveness of combined antibiotic therapy of mycoplasmas was confirmed by microscopic examination. The proposed scheme of decontamination of breast cancer cell culture with combined antibiotics allows to completely destroy mycoplasma infection in cultured cells

Keywords

cell culture; mycoplasma; contamination; identification

Suggested citation
Тkachenko, Т., Kokovin, M., Drozd, P., & Prylutska, S. (2023). Identification of mycoplasma contamination in cell culture. Biological Systems: Theory and Innovation, 14(2), 76-83. https://doi.org/10.31548/biologiya14(3-4).2023.007
References

[1] Ahangaran, S., Pourbakhsh, S.A., Abtin, A., & Asli, E. (2019). Isolation and detection of Mycoplasma pneumoniae from cell culture by culture and PCR. Iranian Journal of Medical Microbiology, 13(3), 153-163. doi: 10.30699/ijmm.13.3.153.

[2] Borup-Christensen, P., Erb, K., & Jensenius, J.C. (1988). Curing human hybridomas infected with Mycoplasma hyorhinisJournal of Immunological Methods, 110(2), 237-240. doi: 10.1016/0022-1759(88)90109-3.

[3] Cando-Dumancela, C., Liddicoat, C., McLeod, D., Young, J.M., & Breed, M.F. (2021). A guide to minimize contamination issues in microbiome restoration studies. Restoration Ecology, 29(4), p. 13358. doi: 10.1111/rec.13358.

[4] Carthew, J., Abdelmaksoud, H., Cowley, K., Hodgson-Garms, M., Elnathan, R., Spatz, J., Brugger, J., Thissen, H., Simpson, K., Voelcker, N., Frith, J., & V. Cadarso. (2021). Next generation cell culture tools featuring Micro- and Nanotopographies for biological screening. Advanced Functional Materials, 32(3), article number 2100881.
doi: 10.1002/adfm.202100881.

[5] Coté, R. (2001). Assessing and controlling microbial contamination in cell cultures. Current Protocols in Cell Biology, 1. doi: 10.1002/0471143030.cb0105s01.

[6] Doyle, M., Vodstrcil, L.A., Plummer, E.L., Aguirre, I., Fairley, C.K., & Bradshaw, C.S. (2020). Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance. Open Forum Infectious Diseases, 7(8), 1-4, article number 291. doi: 10.1093/ofid/ofaa291.

[7] Fay, M.F. (1992). Conservation of rare and endangered plants using in vitro methods. In Vitro Cellular & Developmental Biology – Plant, 28, 1-4. doi: 10.1007/BF02632183.

[8] Jung, H., Wang, S.Y., Yang, I.W., Hsueh, D.W., Yang, W.J., Wang, T.H., & Wang, H.S. (2003). Detection and treatment of mycoplasma contamination in cultured cells. Chang Gung Medical Journal, 26(4), 250-258.
Retrieved from http://cgmj.cgu.edu.tw/2604/260403.pdf.

[9] Lawson-Ferreira, R., Santiago, M.A., Chometon, T.Q., Costa, V.A., Silva, S.A., Bertho, A.L., & de Filippis, I. (2021). Flow-cytometric method for viability analysis of Mycoplasma gallisepticum and other cell-culture-contaminant mollicutes. Current Microbiology, 78(1), 67-77. doi: 10.1007/s00284-020-02255-1.

[10] Ligasová, A., Vydržalová, M., Buriánová, R., Brůčková, L., Večeřová, R., Janošťáková, A., & Koberna, K. (2019). A new sensitive method for the detection of mycoplasmas using fluorescence microscopy. Cells, 8(12), article number 1510. doi: 10.3390/cells8121510.

[11] McNerney, M.P., Doiron, K.E., Ng, T.L., Chang, T.Z., & Silver, P.A. (2021). Theranostic cells: emerging clinical applications of synthetic biology. Nature Reviews Genetics, 22(11), 730-746. doi: 10.1038/s41576-021-00383-3.

[12] Nikfarjam, L., & Farzaneh, P. (2012). Prevention and detection of Mycoplasma contamination in cell culture. Cell Journal, 13(4), 203-212. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584481/.

[13] Pastore, M., Marcone, C., Pennone, F., Cristinzio, G., & Ragozzino, A. (1995). Detection of Mycoplasma-like organisms (MLOs) in apricot by fluorescence microscopy (DAPI) in the South of Italy. Acta Horticulturae, 386, 506-510.
doi: 10.17660/ActaHortic.1995.386.72.

[14] Peng, W., Datta, P., Ayan, B., Ozbolat, V., Sosnoski, D., & Ozbolat, I. T. (2017). 3D bioprinting for drug discovery and development in pharmaceutics. Acta Biomaterialia, 57, 26-46. doi: 10.1016/j.actbio.2017.05.025.

[15] Prylutskyi, Yu.I., Ilchenko, O.V., Tsymbaliuk, O.V., & Kosterin, S.O. (2017). Statistical methods in biology. Kyiv: Scientific Thought.

[16] Regent, F., Morizur, L., Lesueur, L., Habeler, W., Plancheron, A., Ben M’Barek, K., & Monville, C. (2019). Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions. Scientific Reports, 9(1), article number 10646. doi: 10.1038/s41598-019-47123-6.

[17] Strober, W. (2015). Trypan blue exclusion test of cell viability. Current Protocols in Immunology, 111(A3.B.1-A3.B.3). doi: 10.1002/0471142735.ima03bs111.

[18] Timenetsky, J., Santos, L.M., Buzinhani, M., & Mettifogo, E. (2006). Detection of multiple Mycoplasma infection in cell cultures by PCR. Brazilian Journal of Medical and Biological Research, 39(7), 907-914. doi: 10.1590/s0100-879x2006000700009.

[19] Uphoff, C.C., & Drexler, H.G. (2013). Detection of Mycoplasma contaminations. In C. Helgason, & C. Miller (Eds.), Basic cell culture protocols (pp. 1-13), vol 946. Totowa: Humana Press. doi: 10.1007/978-1-62703-128-8_1.

[20] Uphoff, C.C., & Drexler, H.G. (2014). Detection of Mycoplasma contamination in cell cultures. Current Protocols in Molecular Biology, 106(28.4.1-28.4.14). doi: 10.1002/0471142727.mb2804s106.

[21] Uphoff, C.C., Denkmann, S.A., & Drexler, H.G. (2012). Treatment of Mycoplasma contamination in cell cultures with Plasmocin. Journal of Biomedicine & Biotechnology, article number 267678. doi: 10.1155/2012/267678.

[22] Uphoff, C.C., Gignac, S.M., & Drexler, H.G. (1992). Mycoplasma contamination in human leukemia cell lines: I. Comparison of various detection methods. Journal of Immunological Methods, 149(1), 43-53. doi: 10.1016/s0022-1759(12)80047-0.

[23] Uphoff, C.C., Meyer, C., & Drexler, H.G. (2002). Elimination of Mycoplasma from leukemia-lymphoma cell lines using antibiotics. Leukemia, 16(2), 284-288. doi: 10.1038/sj.leu.2402364.

[24] Work, T.S., Work, E., Adams, R.L.P., & Burdon, R.H. (1980). Laboratory techniques in biochemistry and molecular biology: Cell culture for biochemists. New York: North-Holland Publishing Company.

[25] Yin, Z.F., Zhang, Y.N., Liang, S.F., Zhao, S.S., Du, J., & Cheng, B.B. (2019). Mycoplasma contamination-mediated attenuation of plasmid DNA transfection efficiency is augmented via L-arginine deprivation in HEK293 cells. Journal of Zhejiang University – Science, 20(12), 1021-1026. doi: 10.1631/jzus.B1900380.

[26] Young, L., Sung, J., Stacey, G., & Masters, J.R. (2010). Detection of Mycoplasma in cell cultures. Nature Protocols, 5(5), 929-934. doi: 10.1038/nprot.2010.43.

[27] Yu, T., Wang, Y., Zhang, H., Johnson, C.H., Jiang, Y., Li, X., Wu, Z., Liu, T., Krausz, K.W., Yu, A., Gonzalez, F.J., Huang, M., & Bi, H. (2016). Metabolomics reveals mycoplasma contamination interferes with the metabolism of PANC-1 cells. Analytical and Bioanalytical chemistry, 408(16), 4267-4273. doi: 10.1007/s00216-016-9525-9.